LSV Asset Management Boosts Stock Holdings in Tenet Healthcare Corporation $THC

LSV Asset Management grew its stake in shares of Tenet Healthcare Corporation (NYSE:THC) by 6.2% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 235,900 shares of the company’s stock after buying an additional 13,785 shares during the period. LSV Asset Management owned 0.27% of Tenet Healthcare worth $41,518,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in THC. Universal Beteiligungs und Servicegesellschaft mbH raised its holdings in shares of Tenet Healthcare by 12.9% in the 2nd quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 62,153 shares of the company’s stock worth $10,939,000 after purchasing an additional 7,084 shares during the period. Persistent Asset Partners Ltd acquired a new stake in Tenet Healthcare during the 2nd quarter worth approximately $2,204,000. Cetera Investment Advisers lifted its position in Tenet Healthcare by 0.4% during the second quarter. Cetera Investment Advisers now owns 28,924 shares of the company’s stock valued at $5,091,000 after buying an additional 104 shares in the last quarter. Creative Planning increased its position in shares of Tenet Healthcare by 7.4% in the second quarter. Creative Planning now owns 14,980 shares of the company’s stock worth $2,636,000 after acquiring an additional 1,035 shares in the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its holdings in shares of Tenet Healthcare by 5.0% during the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 23,865 shares of the company’s stock valued at $4,200,000 after acquiring an additional 1,133 shares in the last quarter. Institutional investors and hedge funds own 95.44% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have commented on THC shares. UBS Group raised their price objective on Tenet Healthcare from $238.00 to $260.00 and gave the company a “buy” rating in a research report on Wednesday, October 29th. Zacks Research lowered Tenet Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 6th. JPMorgan Chase & Co. increased their price objective on shares of Tenet Healthcare from $200.00 to $230.00 and gave the company an “overweight” rating in a research report on Thursday, November 13th. Guggenheim upped their target price on shares of Tenet Healthcare from $221.00 to $238.00 and gave the company a “buy” rating in a research note on Wednesday, October 29th. Finally, Mizuho lifted their price target on shares of Tenet Healthcare from $194.00 to $225.00 and gave the stock an “outperform” rating in a research note on Friday, October 17th. One analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, Tenet Healthcare presently has an average rating of “Moderate Buy” and a consensus price target of $229.00.

Insider Transactions at Tenet Healthcare

In other news, Director Richard W. Fisher sold 2,500 shares of the business’s stock in a transaction that occurred on Wednesday, October 29th. The stock was sold at an average price of $208.43, for a total value of $521,075.00. Following the completion of the sale, the director directly owned 8,792 shares in the company, valued at approximately $1,832,516.56. The trade was a 22.14% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider R. Scott Ramsey sold 13,322 shares of Tenet Healthcare stock in a transaction on Thursday, November 6th. The stock was sold at an average price of $205.11, for a total transaction of $2,732,475.42. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 122,092 shares of company stock worth $23,844,663 in the last quarter. Insiders own 0.81% of the company’s stock.

Tenet Healthcare Trading Up 0.3%

THC opened at $193.07 on Wednesday. The stock has a market capitalization of $16.97 billion, a PE ratio of 13.23, a P/E/G ratio of 0.89 and a beta of 1.53. The company has a debt-to-equity ratio of 2.27, a current ratio of 1.71 and a quick ratio of 1.63. Tenet Healthcare Corporation has a 12-month low of $109.82 and a 12-month high of $217.43. The firm’s fifty day moving average price is $198.83 and its 200 day moving average price is $179.51.

Tenet Healthcare (NYSE:THC) last issued its earnings results on Tuesday, October 28th. The company reported $3.70 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.33 by $0.37. The business had revenue of $5.29 billion for the quarter, compared to analyst estimates of $5.26 billion. Tenet Healthcare had a net margin of 6.49% and a return on equity of 25.11%. The company’s revenue for the quarter was up 3.2% on a year-over-year basis. During the same quarter in the prior year, the business posted $2.93 EPS. Tenet Healthcare has set its FY 2025 guidance at 15.930-16.26 EPS. As a group, research analysts expect that Tenet Healthcare Corporation will post 12.24 EPS for the current fiscal year.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.